.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Queensland Health
Harvard Business School
AstraZeneca
Fuji
Chubb
UBS
Daiichi Sankyo
Dow

Generated: November 21, 2017

DrugPatentWatch Database Preview

Pharm Res Assoc Company Profile

« Back to Dashboard

What is the competitive landscape for PHARM RES ASSOC, and what generic and branded alternatives to PHARM RES ASSOC drugs are available?

PHARM RES ASSOC has eight approved drugs.



Summary for Pharm Res Assoc

US Patents:0
Tradenames:9
Ingredients:9
NDAs:8
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharm Res Assoc
ATHROMBIN
warfarin sodium
TABLET;ORAL011771-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
CERUMENEX
trolamine polypeptide oleate condensate
SOLUTION/DROPS;OTIC011340-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
ATHROMBIN-K
warfarin potassium
TABLET;ORAL011771-007Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
ATHROMBIN
warfarin sodium
TABLET;ORAL011771-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
SULFABID
sulfaphenazole
SUSPENSION;ORAL013093-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
ATHROMBIN-K
warfarin potassium
TABLET;ORAL011771-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
PHENY-PAS-TEBAMIN
phenyl aminosalicylate
TABLET;ORAL011695-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
T-PHYL
theophylline
TABLET, EXTENDED RELEASE;ORAL088253-001Aug 17, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
PHYLLOCONTIN
aminophylline
TABLET, EXTENDED RELEASE;ORAL086760-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
PHENY-PAS-TEBAMIN
phenyl aminosalicylate
POWDER;ORAL011695-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Colorcon
Cerilliant
Covington
Teva
Federal Trade Commission
Cipla
UBS
Accenture
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot